Volume | 280 262 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 2,63 | Bas Haut |
|||||
Minimum Bas | 2,2501 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
NovaBay Pharmaceuticals Inc New | NBY | AMEX | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,61 | 2,2501 | 2,63 | 2,30 | 2,57 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
3 060 | 280 262 | US$ 2,40 | US$ 673 033 | - | 2,2301 - 44,80 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
02:00:00 | 809 | US$ 2,30 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
14,95M | 6,53M | - | 14,73M | -16,7M | -2,56 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action NovaBay Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
14/6/2024 | 14:47 | Edgar (US Regulatory) | Form 8-K - Current report |
07/6/2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
07/6/2024 | 12:50 | Business Wire | NovaBay Pharmaceuticals Plan of Compliance Accepted by the.. |
31/5/2024 | 22:50 | Edgar (US Regulatory) | Form 8-K - Current report |
31/5/2024 | 22:43 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
31/5/2024 | 03:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
31/5/2024 | 03:29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
31/5/2024 | 03:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
31/5/2024 | 03:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
31/5/2024 | 03:17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/5/2024 | 23:27 | Edgar (US Regulatory) | Form 8-K - Current report |
29/5/2024 | 23:22 | Business Wire | NovaBay Pharmaceuticals Announces Approval of All Proposals.. |
Forum Action NovaBay Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques NovaBay Pharmaceuticals Inc New
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 2,83 | 3,14 | 2,2301 | 2,57 | 279 517 | -0,63 | -22,26% |
1 mois | 5,25 | 6,30 | 2,2301 | 4,89 | 6 880 500 | -3,05 | -58,10% |
3 mois | 4,592 | 9,079 | 2,2301 | 4,71 | 9 747 410 | -2,39 | -52,09% |
6 mois | 10,115 | 10,15 | 2,2301 | 5,00 | 6 152 960 | -7,92 | -78,25% |
1 an | 24,15 | 44,80 | 2,2301 | 6,75 | 3 395 379 | -21,95 | -90,89% |
3 ans | 866,565 | 1 074,57 | 2,2301 | 161,09 | 1 700 043 | -864,37 | -99,75% |
5 ans | 1 984,50 | 2 744,00 | 2,2301 | 746,44 | 2 064 819 | -1 982,30 | -99,89% |